(5R,8S,11R,12S,15S,18S,19S,22R)-15-[3-(diaminomethylideneamino)propyl]-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-1,5,12,19-tetramethyl-2-methylidene-8-(2-methylpropyl)-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopentacosane-11,22-dicarboxylic acid

MCLR; LC-ESI-QFT; MS2; CE: 120%; R=17500; [M+H]+

MCLR; LC-ESI-QFT; MS2; CE: 15%; R=17500; [M+H]+

MCLR; LC-ESI-QFT; MS2; CE: 15%; R=17500; [M-H]-

MCLR; LC-ESI-QFT; MS2; CE: 150%; R=17500; [M+H]+

MCLR; LC-ESI-QFT; MS2; CE: 180%; R=17500; [M+H]+

MCLR; LC-ESI-QFT; MS2; CE: 30%; R=17500; [M+H]+

MCLR; LC-ESI-QFT; MS2; CE: 30%; R=17500; [M-H]-

MCLR; LC-ESI-QFT; MS2; CE: 45%; R=17500; [M+H]+

MCLR; LC-ESI-QFT; MS2; CE: 45%; R=17500; [M-H]-

MCLR; LC-ESI-QFT; MS2; CE: 60%; R=17500; [M+H]+

MCLR; LC-ESI-QFT; MS2; CE: 60%; R=17500; [M-H]-

MCLR; LC-ESI-QFT; MS2; CE: 75%; R=17500; [M+H]+

MCLR; LC-ESI-QFT; MS2; CE: 75%; R=17500; [M-H]-

MCLR; LC-ESI-QFT; MS2; CE: 90%; R=17500; [M+H]+

MCLR; LC-ESI-QFT; MS2; CE: 90%; R=17500; [M-H]-

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 15%; R=15000; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 15%; R=7500; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 30%; R=15000; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 30%; R=7500; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 35%; R=15000; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 35%; R=7500; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 45%; R=15000; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 45%; R=7500; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 60%; R=15000; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 60%; R=7500; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 75%; R=15000; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 75%; R=7500; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 90%; R=15000; [M+H]+

Microcystin-LR; LC-ESI-ITFT; MS2; CE: 90%; R=7500; [M+H]+